SEC Form 4 · accession 0001209191-16-102044
Regulus Therapeutics Inc. · RGLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ALNYLAM PHARMACEUTICALS, INC.
10% Owner
Period of report
Feb 23, 2016
Accepted (ET)
Feb 24, 2016 · 6:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505512
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2016 | S | 1,000,000 | $7.18 | D | 4,896,716 | D |
Table II — derivative securities
No Table II lines on this filing.